This is a short report on the negotiations at the Intergovernmental Working Group on Public Health, Innovation and Intellectual Property. Once again, negotiations were considered unsuccessful by the developing countries as developed countries sought to maintain the status quo, which gives them unfair advantages in intellectual property rights. Negotiations were replete with instances of chicanery and doublespeak on the part of most developed countries, led by the United States. The principal thrust of their strategy has been to obstruct any forward looking measure that would promote the basic objectives of the IGWG, objectives that were designed to find real mechanisms that can promote both innovation and access to medicines that are required for the poor in developing countries.
Health equity in economic and trade policies
This report documents the progression of events in Chiadzwa Zimbabwe in terms of diamond mining and trading, the socio-economic and environmental impacts and the conflict between authorities, (government agencies) and the local communities. The project had as its objective to inform the degree of adherence to the doctrine of 'Permanent Sovereignty over Natural Resources'. The intrusion of mining in Chiadzwa is argued to have displaced the cultural and social mosaic while privatising the commons and subjecting the villagers to several risks and harms with minimal benefits. The existence of clandestine networks is reported to have made an underhand diamond economy
injurious to the prospective diamond-anchored economic resurgence, limiting the benefit sharing arrangements. The authors argue that the extractive nature of the diamond industry should be accompanied with appropriate observance of environmental laws, appropriate corporate social responsibility and transparent accountability by all stakeholders.
Some developing nations nave accused developed nations of overreaching themselves in their push to escalate enforcement of intellectual property rights and want their efforts to be reined in and centralised in the World Intellectual Property Organisation. This especially applies to a secret negotiation led by the United States, Europe and Japan to create an Anti-Counterfeiting Trade Agreement (ACTA). The ACTA might create trade barriers and harm consumers, domestically and outside the signatory nations. The agreement lacks ‘democracy’ and balance, as it relies heavily on industry groups and rights holders with no representation on behalf of consumers. And as the law enforcement side rises, individual legal rights may be diminished. Secrecy around the treaty negotiation has fuelled speculation that its terms will undermine vital consumer interests, including access to low-cost generic medicines.
This report investigates the external debts of both governments and the private sector in the global South. Analysing recently compiled data from international financial institutions, it finds that private sector debt payments out of impoverished countries are now double those of the public sector, a complete turnaround since the year 2000. What is of concern is the fact that similar high levels of private sector debt have been the main cause of the financial crisis in Europe. Across the 32 low- and lower middle-income countries where data is available, private sector external debt payments were found to have increased from 4% of export earnings in 2000 to 10% in 2010. In contrast, government external debt payments for these countries have fallen from 20% of export revenues in 1998 to 5% in 2010. The negative impacts of the financial crisis – including falling trade revenues, loss of money sent home from migrants and multinational companies sending more money back to the rich world – have seen lending to the 35 most impoverished country governments almost double from $5 billion in 2007 to $9 billion in 2009. As a result, government debt payments by impoverished countries are predicted to rise by a third by 2014. Although debt cancellation has released some countries from one debt trap, the Jubilee Debt Campaign argues that the developed country debt crisis has led to an increase in unregulated and opaque private lending, which could increase social inequality and the risk of further economic crisis. A new system for monitoring and regulating the way money moves across the world is needed, so that finance works for the benefit of everyone.
The July 2005 G8 summit in Gleneagles delivered promises on debt, aid, trade, security and climate change. This report examines progress one year later. Debt cancellation has resulted in extra spending on health and education in poor countries, but is not reaching enough of the world's poor. Aid figures show huge increases but include large debt write-offs for Iraq and Nigeria. Oxfam is concerned that the growth in aid in key G8 nations is not enough to meet the promises made at Gleneagles.
The paper concludes that there is no doubt that international trade can play a vital role in promoting sustainable development across the world even though its inter-relationship with the different pillars of sustainable development - economic, environmental and social - is both complex and different in each case. There is equally little doubt that current trade rules need to be reformed to better support environmental and developmental objectives. But whether the Doha 'Development Round' will do this remains an open question.
PART I of this paper provides a brief introduction of the link between trade and development as related to health in general. The history of the World Trade Organisation (WTO) is also briefly introduced as it relates to the General Agreement of Trade in Services (GATS). Then a brief outline of the contents of GATS is given focusing on those areas relevant to public health generally, to health services and to their financing. PART II presents opportunities and threats posed by GATS for public health and health equity goals and policies in southern Africa, in terms of both general obligations and specific commitments across all modes of supply.
The Olle Hansson Award recognises the work of individuals from developing countries who have contributed most to promoting the concepts of essential drugs and their rational use and increasing the awareness among consumers of the dangers of irrational and hazardous drugs.
According to this article, a drugs producer in Uganda has become the first in a least-developed country (LDC) to achieve a world-class seal of quality for its manufacturing standards. The Quality Chemicals plant, in the Ugandan capital Kampala, is the first to get this far along the World Health Organisation (WHO) pre-qualification process, a stringent quality check imposed on manufacturers of drugs. The next step is to gain approval, or pre-qualification, for each malaria and HIV/AIDS drug the firm produces, before international agencies, such as UNICEF, are allowed to buy from the company. It is an important milestone because of scepticism over domestic, or local manufacturing, in such countries, the author notes. There are around 37 manufacturers in sub-Saharan Africa. Pharmaceutical companies from Democratic Republic of the Congo to Ethiopia are being helped to reach international standards too. German development agency GTZ is even sending individual inspectors from the German regulator to Africa to do personal plant assessments. Although no substitute for a full WHO pre-qualification, the process helps identify improvements necessary to reach international standards.
GlaxoSmithKline (GSK) has begun a scheme of tiered pricing of its medicines in low- and middle-income countries. The policy is being tested in India, South Africa and Morocco, to ensure the greatest availability of their products, while still recovering R&D costs from those who are able to pay.